Intracranial Pressure (ICP) Monitoring Market Research Report: Information by Route of Intervention (Intraventricular and Epidural Sensor), Technique (Invasive and Non-Invasive), Application (Traumatic Brain Injury and Subarachnoid Hemorrhage), Device (Intraventricular Catheter and Epidural Sensors), End-User (Hospitals and Clinics, Trauma Centers and others) -Forecast Till 2027
Intracranial Pressure (ICP) Monitoring Market OverviewWith a projected CAGR of 7.1% during the forecast period, the intracranial pressure (ICP) monitoring market expects to touch a market value of USD 2,013.9 million by the end of 2024. The intracranial pressure monitoring device available in the market used to monitor the intracranial pressure works on measuring the pressure inside the skull after a trauma or accident. FREE SAMPLE COPY OF Intracranial Pressure (ICP) Monitoring Market Research Report- Global forecast till 2027” @ https://www.marketresearchfuture.com/sample_request/703 Intracranial pressure monitoring devices are especially designed to measure the pressure within the cranium which is caused by accident and trauma. Such devices are generally used to treat traumatic brain injury. ICP measures the pressure in the skull by placing a small probe in the skull. The probe is further attached at the other end to a monitor. The device helps to sense the pressure caused inside the skull and transports the measurements to a recording device. Market Potential and Pitfalls With the increasing incidences of neurovascular diseases like brain aneurysm and arteriovenous malformations, the global intracranial pressure (ICP) monitoring market is predicted to foster during the forecast period. The increased expenditure on healthcare coupled with the strong demand for therapeutics is some of the chief factors propelling the market growth across the globe. The market is slated to exhibit a sturdy growth rate owing to the introduction of favorable reimbursement policies which aim towards the betterment of the public. Moreover, the surging biotechnology sector is likely to cause a shift in the sector and result in the growth of ICP monitoring market. With the emergence of advanced ICP monitoring devices, the limitations of earlier devices like leveling and de-bubbling of fluid-filled systems and shift in baseline pressure have been eliminated. Advanced monitors enable surgeons to monitor a patient closely and offer effective treatment. The non-invasive ICP monitoring methods do not measure absolute ICP. Therefore, the validation and development of non-invasive intracranial pressure which is capable of measuring absolute ICP device will create great opportunities for the growth of the ICP monitor market. The rising prevalence of stroke and traumatic surgeries has highly influenced the intracranial pressure monitoring market across the globe. Moreover, the upswing in cases of brain surgeries in adults as well as children has triggered the demand for ICP monitors. On the contrary, high procedural costs of such devices coupled with the dearth of skilled personnel are some of the concerns anticipated to deter the market growth in the coming years. Global Intracranial Pressure (ICP) Monitoring Market: Segmental Analysis The global intracranial pressure (ICP) monitoring market has been segmented on the basis of technique, route of intervention, application, device, and end-user. By mode of route of intervention, the global intracranial pressure (ICP) monitoring market has been segmented into epidural and intraventricular sensor. By mode of technique, the global intracranial pressure (ICP) monitoring market has been segmented into non-invasive and invasive. By mode of devices, the global intracranial pressure (ICP) monitoring market has been segmented into subarachnoid screw, intraventricular catheter, non-invasive ICP monitors, and epidural sensors. By mode of applications, the global intracranial pressure (ICP) monitoring market has been segmented into intracerebral hemorrhage, traumatic brain injury, meningitis, and subarachnoid hemorrhage. Among these, the traumatic brain injury segment is anticipated to hold a significant share in the global market due to its vast prevalence globally. By mode of end-users, the global intracranial pressure (ICP) monitoring market has been segmented into trauma centers and hospitals & clinics. Intracranial Pressure (ICP) Monitoring Market Regional Insights Geographically, the intracranial pressure (ICP) monitoring market span across regions namely, Europe, America, Asia Pacific, and the Middle East & Africa. Among all the regions, the American region is considered to lead the global intracranial pressure (ICP) monitoring market. The growth is credited to the increasing number of patients suffering from moderate to severe brain injury. Moreover, awareness regarding neurodegenerative disease coupled with the constant initiatives undertaken by the government for offering a better infrastructure is predicted to contribute to the market growth in this region. The Asia Pacific region is considered to expand at the fastest rate owing to the presence of a large patient pool suffering from brain disorders. Moreover, government initiatives and the presence of well-established critical care centers and hospitals are further estimated to boost the market in this region. Industry Updates June 01, 2018: A company dedicated to offering cost-effective mobile solutions for ICP, Branchpoint Technologies has recently announced that the U.S. FDA has granted 510(k) clearance for its AURA ICP Monitoring System. The system comprises a fully wireless and implantable ICP sensor, enabling truly mobile ICP monitoring in patients with brain-injury. Competitive Dashboard The prominent players operating in the global intracranial pressure (ICP) monitoring market are
OBTAIN RESEARCH REPORT DETAILS WITH TOC @ https://www.marketresearchfuture.com/reports/intracranial-pressure-monitoring-market-703 About Market Research Future: At Market Research Future (MRFR), we enable our customers to unravel the complexity of various industries through our Cooked Research Report (CRR), Half-Cooked Research Reports (HCRR), Raw Research Reports (3R), Continuous-Feed Research (CFR), and Market Research & Consulting Services.
0 Comments
Veterinary Ultrasound Market Share By Manufacturers, Detailed Analysis, Revenue Growth 202710/23/2021 Automated Cell Culture Equipment Market Rapidly Growing in Healthcare, Competitor Analysis 202710/23/2021 Global Automated Cell Culture Equipment Market: Information by Lab Automation Type (Modular Automation and Whole Lab Automation), by Product Type (Consumables, Equipment and Software), By Application (Biopharmaceutical Production, Tissue Engineering, Vaccine Production, Gene Therapy & Regenerative Medicine, Stem Cell Therapy, Toxicity Testing and Diagnostics), By End User (Pharmaceutical & Biotechnology Companies, Research and Academic Institutes and Hospitals and Diagnostic Laboratories) – Forecast till 2027
Market Highlights Automated Cell Culture Equipment Market is estimated to be valued at USD 4,906.53 Million by 2025 and is expected to register a CAGR of 12.04% during the forecast period. Automated cell culture equipment aids in maximizing accuracy, precision, and minimizes time and consumable costs. The global automated cell culture equipment market is witnessing a significant market growth due to enhanced productivity and good quality of cell lines than manual cell culture equipment. Get Sample Report at https://www.marketresearchfuture.com/sample_request/8770 The growing research & development (R&D) initiatives in the pharmaceutical industry, rise in adoption of liquid handling systems, and increasing prevalence of cancer and other infectious diseases are expected to drive the growth of this market during the forecast period. However, high maintenance costs, lack of awareness, and shortage of skilled professionals are restraining the growth of the market. The increasing focus on regenerative medicine is likely to create an opportunity for the growth of the global automated cell culture equipment market. Market Players Market Research Future (MRFR) recognizes Tecan Trading AG, Hamilton Company, Beckman Coulter, Inc., Pfizer Inc., Hitachi, Ltd, F. Hoffmann-La Roche Ltd., Thermo Fisher Scientific Inc., Anton Paar GmBH, Sartorius AG, Perkinelmer, Inc., and Siemens as the key players in the global automated cell culture equipment market. Segment Analysis The Global Automated Cell Culture Equipment Market has been segmented into lab automation type, product type, application, and end-user. Based on the lab automation type, the global automated cell culture equipment market has been segmented into modular automation and whole lab automation. The modular automation segment accounted for the largest market share of 67.20% in 2018, with a market value of USD 1484.16 million, which is projected to register a CAGR of 11.68% during the forecast period. On the basis of product type, the global automated cell culture equipment market has been classified into consumables, equipment, and software. Based on application, the global automated cell culture equipment market is segmented into biopharmaceutical production, tissue engineering, vaccine production, drug screening and development, gene therapy & regenerative medicine, stem cell therapy, toxicity testing, diagnostics, and others. On the basis of end-user, the global automated cell culture equipment market has been segmented into pharmaceutical & biotechnology companies, research and academic institutes, and hospitals and diagnostic laboratories, and others. Regional Analysis The global automated cell culture equipment market has been segmented based on region, into the Americas, Europe, Asia-Pacific, and the Middle East & Africa. The existence of key market players, a well-developed healthcare infrastructure, significant per capita healthcare spending, high funding for research & development, focused research on cancer along with grants from government healthcare agencies, and high adoption of advanced medical technologies in the US and Canada are likely to support the dominance of the Americas on this market during the forecast period. According to the American Cancer Society, in 2019, an estimated 1,762,450 new cancer cases are expected to be diagnosed. The US expenditure for cancer care was approximately USD 147.3 billion in 2017. This high incidence of cancer cases and growing investment in R&D to develop new treatment options is expected to drive the American automated cell culture equipment market during the forecast period. Access Report Details @ https://www.marketresearchfuture.com/reports/automated-cell-culture-equipment-market-8770 About US: Market Research Future (MRFR) enable customers to unravel the complexity of various industries through Cooked Research Report (CRR), Half-Cooked Research Reports (HCRR), Raw Research Reports (3R), Continuous-Feed Research (CFR), and Market Research & Consulting Services. Celiac Disease Treatment Market Industry Experts And Business Overview To Forecast By 202710/21/2021 Automated Cell Culture Equipment Market Global Trends, Business Opportunity and Challenges 202710/21/2021 Global Life Sciences BPO Market: By Service Type (Contract Research (Drug Discovery, Pre-Clinical Trials, Clinical Trials, Medical Writing, Pharmacovigilance, Clinical Data Management, Regulatory Services, Clinical Monitoring, Protocol Development and Site Management), Contract Manufacturing, Contract Sales and Marketing), Application (Medical Devices, Pharmaceutical and Biopharmaceuticals) - Forecast to 2027
GET FREE SAMPLE COPY @ https://www.marketresearchfuture.com/sample_request/10167 Market Forecast Global Life Sciences BPO Market is expected to cross USD 427.78 Billion by 2027 at a CAGR of 13.60%. Regional Analysis On a regional basis, the Americas is anticipated to dominate the global life sciences BPO market, owing to the factors such as well-established healthcare sector, presence of ample biotechnology and pharmaceutical companies, new technological advancements in life sciences industry, major giants in the market involved in merger & acquisition, and new product innovation. Technologies such as Artificial Intelligence (AI), Machine Learning (ML) are playing a significant role in the life science BPO industry, while significantly reducing costs involved with mapping highly complex studies. Companies are adopting these technologies for drug discovery. For instance, in June 2019, Navitas Life Sciences (US) in partnership with ThoughtSphere (US) Company adopted AI and ML technologies to deliver unparalleled data collection. On the other hand, Europe is expected to hold the second-largest position in the global life sciences BPO market, due to the favorable regulatory scenario to support the outsourcing process in the life sciences industry. For instance, in 2020, UK Medicines and Healthcare products Regulatory Agency (MHRA) and the European Medicines Agency (EMA) issued guidance on how investigators and sponsors should manage clinical trials during the outbreak. Such moves are set to increase the European life science industry. Asia-Pacific is anticipated to be the fastest-growing region over the assessment period due to the rising demand for outsourcing in the life science industry, and the rising importance of safety & security of products. Initiatives by the government such as the introduction of ICD-10 standards that capture the inpatient procedures has supported the rising adoption of electronic health records (EHR), electronic laboratory notebook (ELN) in the life sciences industry. These digital platforms enable the rapid growth of the back-end payer and provider BPO services, such as claims processing, claims management, financial and payroll management, and other administrative services. Furthermore, the growth of the Middle East & Africa is attributed to the technological development in the field of medical and healthcare industry, high penetration of advanced healthcare technologies in research organizations such as Saudi Arabia and UAE. Segmentation Global Life Sciences BPO Market has been segmented into Service Type, and Application. By Service Type, the market has been segregated into contract research, contract manufacturing, contract sales, and marketing. Growing focus on core activities by pharmaceutical companies, increasing the cost of drug development, clinical trial activities, regulatory constraints are primarily driving the market growth. Based on the Application, the global life sciences BPO market has been classified into medical devices and biopharma and pharmaceuticals. The medical devices segment is expected to be the fastest growth owing to the increasing number of medical companies opting to outsource their strategic and non-strategic processes to vendors to improve their return on investment (ROI), maintain profitability, product quality, and cost, and to meet capacity constraints. Pharmaceuticals and biopharmaceuticals segment held the largest segment in the life sciences BPO market owing to the increased clinical trial of drugs. Key Players Some of the Key Players in the Global Life Sciences BPO Market are Accenture plc (Ireland), Boehringer Ingelheim GmbH (Germany), Charles River Laboratories International, Inc. (US), Covance, Inc. (US), Genpact Limited (US), Catalent, Inc. (US), Infosys (India), Health Decisions, Inc. (US), Anthelio Healthcare Solutions (India), Cognizant Technology Solutions (US), ProMab Biotechnologies, Inc. (US), Quintiles Transnational Corporation (US), Paraxel International Corporation (US), Lonza Group (Switzerland). Access Report Details @ https://www.marketresearchfuture.com/reports/life-sciences-bpo-market-10167 About Market Research Future: At Market Research Future (MRFR), we enable our customers to unravel the complexity of various industries through our Cooked Research Report (CRR), Half-Cooked Research Reports (HCRR), Raw Research Reports (3R), Continuous-Feed Research (CFR), and Market Research & Consulting Services. Global Bionic Ear Market: By Device Type (Cochlear Implant, Auditory Brainstem Implants, Bone-Anchored Hearing Aid), By End User (Research Institutes, Hearing Clinics, Hospitals), and Region (North America, Europe, Asia-Pacific, Rest of the World)—Forecast to 2027
Market Forecast The global bionic ear market is expected to cross ~USD 26,980.20 million by 2027 at a CAGR of ~8.10% during the forecast period. get free sample copy @ https://www.marketresearchfuture.com/sample_request/10644 Regional Analysis On aregional basis, the North Americais anticipated to dominate the global bionic ear market dueto the factors such as the presence of leading service providers in this region involved in R&D activity.An increase in public awareness among people and improved diagnostic facilities, and technological advancements in bionic ears greatly impact business development. In addition, the presence of the major giants in the market involved in mergers&acquisitions and new product innovation is another driving the market growth. For instance, in May 2021, Sonova acquired the Consumer Division from Sennheiser electronic GmbH & Co. KG (Sennheiser), which concentrates on the business of headphones and hearables for private customers, is an excellent fit with Sonova's strategy to lead innovation in hearing experience and to engage consumers early on their hearing journey. Additionally, in July 2017, Cochlear Limited introduced Cochlear Nucleus 7 Sound Processor into the US market. It was by the US FDA. Segmentation The bionic ear market is segmented by device type, enduser, and region. Based on the device type, the bionic ears market segments into cochlear implants, auditory brainstem implants, and bone-anchored hearing aid.The cochlear implant segment is expected to hold a significant share of the market in 2020. Cochlear implant is found to be effective than traditional devices. These devices enhance the sound quality and thus improve a person's ability to better understand a speech.It also helps to regain the sound even in a noisy environment and is even considered safe for children to use it. Key Players Some of the key market players includeAdvanced Bionics (US), Sonova (Switzerland), Cochlear (Australia), MED-EL (Austria), Sivantos/ WS Audiology ( Singapore), Oticon (Denmark), Hangzhou Nurotron (China), Listent Medical (China), Medtronic PLC (Ireland), Edward Lifesciences Corporation (US), Ekso Bionics (US), Ossur (Iceland), LifeNet Health (US),William Demant Holdings (Denmark), and Terumo Corporation (Japan). Access full report @ https://www.marketresearchfuture.com/reports/bionic-ear-market-10644 About Market Research Future: At Market Research Future (MRFR), we enable our customers to unravel the complexity of various industries through our Cooked Research Report (CRR), Half-Cooked Research Reports (HCRR), Raw Research Reports (3R), Continuous-Feed Research (CFR), and Market Research & Consulting Services. MRFR team have supreme objective to provide the optimum quality market research and intelligence services to our clients. Our market research studies by Components, Application, Logistics and market players for global, regional, and country level market segments, enable our clients to see more, Medical ceramics are primarily used in the making of surgical implants, dentures, prosthetics & joints, and various medical equipment & devices. This versatile biomaterial also finds its vast applications in tissue engineering and gene therapy. The extensive application leads to garnering huge market prominence for medical ceramics, worldwide. Resultantly, the medical ceramics market is witnessing colossal traction on a global platform.
According to Market Research Future (MRFR), the global Medical Ceramics Market is projected to register 6.5% CAGR during 2017-2023, witnessing exponential accruals by2023. Augmented demand and growing application areas in the medical space are some of the key driving forces behind the growth of the medical ceramics market. Additionally, the growing prevalence of cardiovascular disorders alongside the rising geriatric population foster market growth. Get Sample Copy @ https://www.marketresearchfuture.com/sample_request/5729 Rise in dental care due to the growing awareness among people for the overall oral health impacts the growth of the medical ceramics market. Also, the increasing patient population for dental diseases influences market growth, hugely. Besides, government initiatives and funding support help increase the size of the global medical ceramics market. Moreover, factors such as the rising demand for advanced treatment and increasing product developments in the medical devices and surgical equipment market provide a massive impetus to the market growth. Conversely, high costs of medical ceramics are expected to act as a major growth impeder for the growth of the market, encouraging the development of similar, low-cost materials. Nevertheless, increasing sales of medical ceramics would support market growth, defining the growing market landscape. Global Medical Ceramics Market – Segments For the scope of understanding, the report has been segmented into four key dynamics. By Type : Bioactive Ceramics, Piezoceramics, Bioinert Ceramics, Bioresorbable Ceramics, and others. By Application : Orthopedic, Dental, Plastic Surgery, Cardiovascular & Diagnostic Instruments, and others. By End-user : Hospitals & Clinics, Specialty Centers, and others. By Regions : Europe, Americas, Asia Pacific, Middle East & Africa, and Rest-of-the-World. Global Medical Ceramics Market – Geographical Analysis North America dominates the global medical ceramics market due to the presence of many matured players that can deliver a range of customized solutions and their substantial investments. Additionally, factors such as the increasing numbers of patients affected by chronic diseases & disorders substantiate the market growth in the region, creating the demand for technologically advanced treatments & products. Also, rising demand for ceramic medical products such as dental and bone implants and surgical ceramics is projected to aid in creating a larger revenue pocket for the regional market during the forecast period. Moreover, rising government support and the growing use of ceramics in the manufacturing of medical equipment and devices foster the growth of the regional market. Continuing with the same growth trends, the North American medical ceramics market is estimated to continue with its leading position. Europe stands second in the global medical ceramics market. Large technological advances and the augmented adoption of advanced ceramics among healthcare providers, mainly in the UK, Germany, and France, drives the regional market growth. Also, rising cases of dental disorders and an increase in population awareness towards health are accelerating the growth in the medical ceramics market. Besides, the resurging economy in the region acts as a major tailwind behind the growth of the European medical ceramics market. Asia Pacific is rapidly emerging as a lucrative market for medical ceramics, globally. Factors such as the rising cases of demand for Joint replacements that are coated with bioceramic materials to reduce wear and inflammatory response are driving the regional market growth. Moreover, increasing incidences of chronic diseases are creating a huge demand for pacemakers, kidney dialysis machines, and respirators. Besides, rising government support and the increase in the per-capita healthcare expenditures are impacting the market growth in the region, positively. With the ever-increasing population in the region that is increasingly gaining awareness for health management, the APAC medical ceramics market is forecasted to register an impressive CAGR during the assessment period. Global Medical Ceramics Market – Competitive Analysis Highly competitive, the medical ceramics market appears to be fragmented, with many well-established players forming the competitive landscape. Brand reinforcement, innovation, and new technology launch remain the popular trends for the key players in the market. Matured players invest colossally in R&D and to acquire other promising companies. These well-established players target more investments in the development of technology to upgrade their existing products. They also strive to deliver the high-purity product manufactured with the highest standards. Major Players: Players leading the global medical ceramics market include Zimmer Holdings, Inc., Straumann, CoorsTek Inc., Kyocera Corporation, 3M ESPE, Stryker, H.C. Starck GmbH, DePuy Synthes, Nobel Biocare Services AG, and Morgan Advanced Materials, among others. Industry/Innovation/Related News: December 02, 2019 —- Advanced Medical Solutions Group plc. (AMS – the UK), announced its acquisition of a leading global innovative surgical biomaterial technologies provider – Biomatlante SA (France). Biomatlante has a patent-protected technology platform with a wide range of biomaterial products used in orthopedic, spinal, dental, and sports surgery and a development pipeline of next-generation products. The acquisition would strengthen AMS’s product portfolio, R&D pipeline, and market access to a wide range of biomaterial products. Additionally, the deal provides the Group with a range of revenue-generating surgical products and an R&D pipeline of complementary bio-surgical technologies. It would also offer significant growth potential in additional surgical markets. OBTAIN RESEARCH REPORT DETAILS WITH TOC @ https://www.marketresearchfuture.com/reports/medical-ceramics-market-5729 About Market Research Future: At Market Research Future (MRFR), we enable our customers to unravel the complexity of various industries through our Cooked Research Report (CRR), Half-Cooked Research Reports (HCRR), Raw Res HERG Screening Market: Information By Type (Gene KCNH2, Mutant KCNH2), Ion Channel (Voltage-gated ion channel, Ligand-gated ion channel), Application (Antiarrhythmic, Antipsychotic, Antibiotics) and Region (Americas, Europe, Asia-Pacific and the Middle East and Africa) - Forecast till 2027
GET FREE SAMPLE @ https://www.marketresearchfuture.com/sample_request/10386 HERG Screening Market Overview: HERG Screening Market is expected to register a CAGR of 13.85% during the assessment period of 2020 to 2027, to reach USD 3,304.58 Million by 2027. hERG screening has been an important component of cardiac safety-pharmacology from the past many years. hERG was identified as a potassium-selective cardiac ion channel, Kv11.1, which plays an important role during cardiac repolarization. Segment Analysis Global hERG Screening Market is segmented into Type, i.e., gene KCNH2 and mutant KCNH2. KCNH2 gene that provides guidelines for producing potassium channels and held the largest market share in the hERG screening market. The global hERG screening market is segmented based on ion channel, further bifurcated into voltage-gated ion channel, ligand-gated ion channel, and others. Voltage-gated ion channel held the largest share in the hERG screening market, whereas ion-gated channel is the fastest-growing segment. The application segment is divided into antiarrhythmic drugs, antipsychotics, antibiotics, and others. The antiarrhythmic drug application segment is projected to account for a considerable market share. Regional Analysis The global hERG screening market, based on region, has been divided into the Americas, Europe, Asia-Pacific, and the Middle East & Africa. The Americas has been segmented into North America and Latin America, with the North America market further divided into the US and Canada. The Americas held the largest share of 37.3% of the hERG screening market in 2019. This share can be attributed to technological development and the high prevalence of cardiac disease in the region. The Europe hERG screening market has been segmented into Western Europe and Eastern Europe. The Western Europe hERG screening market has further been classified into Germany, France, the UK, Italy, Spain, and the Rest of Western Europe. The major players of these countries are involved in new launches and acquisitions in the hERG screening market. The hERG screening market in Asia-Pacific has been segmented into China, India, Japan, South Korea, Australia, and the Rest of Asia-Pacific. The market growth in these countries is attributed to the large pool of patients suffering from cardiac disorders and the need for drug formulation and development to cure these disorders. The Middle East & Africa hERG screening market has been divided into the Middle East and Africa. Browse Full Report Details @ https://www.marketresearchfuture.com/reports/herg-screening-market-10386 Key Players MRFR recognizes the following companies as the Key Players in the Global hERG Screening Market—Thermo Fisher Scientific, Eurofins Discover X Corporation, Charles River Laboratories, Merck KGaA, Metrion Biosciences Ltd, and Aurora Biomed, Inc. About Market Research Future: At Market Research Future (MRFR), we enable our customers to unravel the complexity of various industries through our Cooked Research Report (CRR), Half-Cooked Research Reports (HCRR), Raw Research Reports (3R), Continuous-Feed Research (CFR), and Market Research & Consulting Services. |
AuthorWrite something about yourself. No need to be fancy, just an overview. Archives
October 2021
Categories |